The chemical maker's December quarter saw a sharp margin squeeze, with profit falling over half despite steady revenue, as input costs and plant shutdowns weighed.
Tanfac Industries' Q3 FY26 profit fell 55% year-on-year to ₹15.6 crore, even as revenue held relatively steady. The plunge was driven by a sharp rise in raw material costs and operational expenses that compressed margins significantly.
For Tanfac Industries, a steady top line was no defence against a cost surge this quarter. The fluorine chemical specialist reported a 55% plunge in net profit, a stark reminder that in commodity-linked manufacturing, pricing power is everything when inputs turn.
The numbers tell a story of divergence. Revenue was nearly flat at ₹173.6 crore, down just 2.7% from a year ago. But profit collapsed to ₹15.6 crore, dragging the net profit margin down by 10.5 percentage points to just 9%. Sequentially, revenue inched up 2.5% while profit fell another 9.4%.
Revenue & profit
Revenue (₹ Cr)
Profit (₹ Cr)
Revenue (₹ Cr)
Profit (₹ Cr)
Net Profit Margin
| Metric | CurrentQ3 FY26 | PreviousQ2 FY26 | Same quarter LYQ3 FY25 |
|---|---|---|---|
| Revenue (₹ Cr) | 173.57YoY -2.7% | 169.31 | 178.39 |
| Profit (₹ Cr) | 15.57YoY -55% | 17.18 | 34.80 |
| Net Profit Margin | 9.0%YoY -54% | 10.1% | 19.5% |
Management, cited by Business Standard, pointed to a steep increase in a key input cost and reduced production from a plant shutdown. The annual maintenance and commissioning work for the new Solar Grade DHF project limited output. ScanX News detailed a 16% rise in total expenses, led by a 10% jump in raw material costs and a nearly 20% increase in employee benefits.
The cost pass-through to customers, a critical lever, operates with a lag. On a recent earnings call, management noted it can pass on 100% of cost increases, but the process typically takes 30 to 40 days. In a quarter of rapidly rising costs, that delay directly hits margins.
The near-term outlook hinges on this pass-through catching up and new capacity ramping up. The company's Solar Grade DHF plant, commissioned in phases through 2025, is expected to support growth. A major ₹495 crore downstream fluorinated chemicals expansion is also underway, targeting commissioning by November 2026.
Live Chart
· TANFAC INDUSTRIES
(BSE)
ISIN: INE639B01015
The market reaction was predictably negative, with the stock falling sharply post-results. MarketsMojo downgraded the stock to 'Sell', citing deteriorating profitability and expensive valuations. The stock trades at a P/E of 53.6, a 35% premium to its industry, a multiple that demands growth the quarter did not show.
Key Points
This quarter underscores Tanfac's vulnerability to input cost volatility before new, higher-margin products reach scale. The 10.5 percentage point margin contraction is severe, and a return to mid-teens profitability requires the promised pass-through to materialize fully in the coming quarter.
The investment case now leans heavily on the timely execution of the downstream expansion. If the new capacities ramp up as planned and start contributing meaningfully by late FY27, the current cost pressure could be seen as a transitional phase. Until then, the stock's rich valuation lacks the earnings support to justify it.
Also read
Want this applied to your portfolio?
Talk to a HexaWealth advisor, or sync your mutual fund data for insights tailored to your holdings.